Pharmaris Holdings (2796) Reports Earnings: Operating Income Decreases 54.8% YoY to 68 Million Yen

Pharmaris Holdings (2796) has released its financial results, reporting net sales of 17,242 million yen, a 2.9% increase compared to the same period of the previous year. Despite the top-line growth, profitability was impacted, with operating income decreasing by 54.8% YoY to 68 million yen and ordinary income declining by 31.3% to 79 million yen. The company posted a net loss attributable to owners of the parent of 36 million yen (earnings per share of -3.2 yen), with comprehensive income standing at -43 million yen.

From a financial and valuation perspective, the equity-to-asset ratio is 20.6%. While interest-bearing debt stands at 13.83 billion yen, retained earnings are recorded at 2.70 billion yen. As the company navigates a challenging profit environment despite steady revenue growth, market participants will likely monitor future measures aimed at improving operational efficiency and strengthening the financial foundation.